JM

Cascade BioSciences Inc.

TSX: CSBX

Mid-cap oncology developer. Lead candidate CSB-204 in Phase II. Disclosure quality has deteriorated across the last two reporting cycles.

OverviewFlagsFilingsContradictionsRisksNetworkEnforcementInsider trades

Local relationship graph

View in global network
CSBX
Zoom 100%
issuer
person
auditor
address